HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$32.85
Day range
$31.38 - $33.08
Year range
$26.20 - $63.50
Market cap
1.92B USD
Avg Volume
828.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 75.88M | 104.23% |
Net income | -67.22M | -111.81% |
Net profit margin | — | — |
Earnings per share | -1.20 | -275.00% |
EBITDA | -75.80M | — |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 520.65M | 31.66% |
Total assets | 753.95M | 87.83% |
Total liabilities | 37.16M | 72.90% |
Total equity | 716.79M | — |
Shares outstanding | 58.09M | — |
Price to book | 2.66 | — |
Return on assets | -24.79% | — |
Return on capital | -25.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -67.22M | -111.81% |
Cash from operations | -67.71M | -127.58% |
Cash from investing | 46.37M | 216.82% |
Cash from financing | 44.36M | 20,924.41% |
Net change in cash | 23.01M | 133.03% |
Free cash flow | -44.78M | -144.96% |
About
Founded
2022
Headquarters
Website
Employees
196
